STAGE IV PROSTATE CANCER
Clinical trials for STAGE IV PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test 'Adaptive' hormone therapy to outsmart prostate cancer
Disease control OngoingThis small, early-stage study is testing a personalized approach to hormone therapy for men with advanced prostate cancer that still responds to hormone treatment. Instead of giving medication continuously, doctors will adjust the timing and dose based on each patient's PSA level…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug duo trial targets prostate Cancer's genetic weakness
Disease control OngoingThis study is testing whether combining two existing drugs works better than using them alone for men with advanced prostate cancer that has specific genetic flaws. It is for men whose cancer has spread and is no longer responding to standard hormone-blocking treatments. The tria…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test 'One-Two Punch' strategy to fight advanced prostate cancer
Disease control OngoingThis study is testing a two-step treatment plan for men with high-risk prostate cancer that has spread. First, patients receive strong hormone-blocking drugs. Then, they receive chemotherapy combined with hormone therapy. The goal is to see if this sequence can better control the…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Double attack on prostate cancer: testing a drug combo for tough cases
Disease control OngoingThis study is for men with advanced prostate cancer that has stopped responding to standard hormone therapy and has spread to the bones. It aims to see if adding a targeted radiation drug (Radium223) to a standard cancer-fighting pill (enzalutamide) works better than the pill alo…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Triple-Threat attack on prostate cancer shows promise
Disease control OngoingThis early-stage trial is testing whether combining three different treatments is safe for men with aggressive prostate cancer. The approach uses a hormone-blocking drug (enzalutamide), radiation therapy, and standard hormone injections to attack the cancer from multiple angles. …
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC
-
Brain scans reveal hidden side effects of prostate cancer drugs
Knowledge-focused OngoingThis study investigates whether two common prostate cancer drugs (abiraterone acetate and enzalutamide) affect thinking, memory, and brain function. Researchers are following 100 men with advanced prostate cancer, using brain scans and cognitive tests to measure changes over time…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC